Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-04-15 4:11 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | BIOTECHNOLOGY VALUE FUND L P | 6,631,051 10.1% | 2,109,000 (+46.64%) | View |
| 2021-03-09 2:31 pm Unchanged | 13G | OVID THERAPEUTICS INC OVID | EcoR1 Capital Fund L.P. | 6,082,200 9.6% | 0 (Unchanged) | View |
| 2021-03-09 1:19 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | EcoR1 Capital Fund L.P. | 6,082,200 9.6% | 6,082,200 (New Position) | View |
| 2021-02-17 3:13 pm Sale | 13G | OVID THERAPEUTICS INC OVID | Consonance Capital Management LP | 0 0% | -6,058,505 (Position Closed) | View |
| 2021-02-16 4:39 pm Sale | 13G | OVID THERAPEUTICS INC OVID | During Matthew | 4,020,794 6.3% | -964,811 (-19.35%) | View |
| 2021-02-16 4:37 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | LEVIN JEREMY M | 6,092,270 9.6% | 369,337 (+6.45%) | View |
| 2021-02-16 2:22 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | Consonance Capital Management LP | 6,058,505 11% | 3,169,617 (+109.72%) | View |
| 2021-02-12 4:18 pm Sale | 13G | OVID THERAPEUTICS INC OVID | BIOTECHNOLOGY VALUE FUND L P | 4,522,051 6.9% | -733,250 (-13.95%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | BlackRock Inc. BLK | 3,411,733 5.4% | 2,756,291 (+420.52%) | View |
| 2021-01-05 3:12 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | SINGER JAMES R | 3,000,000 4.7% | 150,000 (+5.26%) | View |
| 2020-05-27 11:59 am Sale | 13D | OVID THERAPEUTICS INC OVID | TLS Advisors LLC | 2,489,415 4.55% | -477,450 (-16.09%) | View |
| 2020-05-13 2:54 pm Purchase | 13D | OVID THERAPEUTICS INC OVID | TradeLink Holdings LLC | 2,489,415 4.55% | 2,489,415 (New Position) | View |
| 2020-03-27 08:56 am Purchase | 13G | OVID THERAPEUTICS INC OVID | SINGER JAMES R | 2,850,000 5.2% | 495,000 (+21.02%) | View |
| 2020-02-14 2:29 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | BIOTECHNOLOGY VALUE FUND L P | 5,255,301 9.99% | 1,483,301 (+39.32%) | View |
| 2020-02-14 2:10 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | Consonance Capital Management LP | 2,888,888 6.04% | 2,888,888 (New Position) | View |
| 2020-02-14 1:23 pm Sale | 13G | OVID THERAPEUTICS INC OVID | ARMISTICE CAPITAL LLC | 0 0% | -1,600,000 (Position Closed) | View |
| 2020-02-14 09:29 am Purchase | 13G | OVID THERAPEUTICS INC OVID | During Matthew | 4,985,605 10.3% | 161,502 (+3.35%) | View |
| 2020-02-14 09:26 am Sale | 13G | OVID THERAPEUTICS INC OVID | LEVIN JEREMY M | 5,722,933 11.7% | -78,095 (-1.35%) | View |
| 2020-01-17 4:01 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | SINGER JAMES R | 2,355,000 4.9% | 985,000 (+71.90%) | View |
| 2019-11-27 1:15 pm Sale | 13D | OVID THERAPEUTICS INC OVID | TLS Advisors LLC | 2,966,865 6.2% | -499,529 (-14.41%) | View |